BR112013018742A2 - cya-transportador de polipeptídeo(s) e use para induzir tanto as terapias e resposta imunitária profilática - Google Patents
cya-transportador de polipeptídeo(s) e use para induzir tanto as terapias e resposta imunitária profiláticaInfo
- Publication number
- BR112013018742A2 BR112013018742A2 BR112013018742A BR112013018742A BR112013018742A2 BR 112013018742 A2 BR112013018742 A2 BR 112013018742A2 BR 112013018742 A BR112013018742 A BR 112013018742A BR 112013018742 A BR112013018742 A BR 112013018742A BR 112013018742 A2 BR112013018742 A2 BR 112013018742A2
- Authority
- BR
- Brazil
- Prior art keywords
- therapies
- induce
- immune response
- prophylactic immune
- polypeptide transporter
- Prior art date
Links
- 230000028993 immune response Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001186—MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11305069A EP2478915A1 (en) | 2011-01-24 | 2011-01-24 | CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses |
| PCT/EP2012/051027 WO2012101112A1 (en) | 2011-01-24 | 2012-01-24 | Cyaa-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013018742A2 true BR112013018742A2 (pt) | 2017-11-14 |
Family
ID=43971828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013018742A BR112013018742A2 (pt) | 2011-01-24 | 2012-01-24 | cya-transportador de polipeptídeo(s) e use para induzir tanto as terapias e resposta imunitária profilática |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9902947B2 (pt) |
| EP (2) | EP2478915A1 (pt) |
| JP (2) | JP6014604B2 (pt) |
| KR (1) | KR101975610B1 (pt) |
| CN (1) | CN103476424A (pt) |
| AU (1) | AU2012210612B2 (pt) |
| BR (1) | BR112013018742A2 (pt) |
| CA (1) | CA2825470A1 (pt) |
| ES (1) | ES2748381T3 (pt) |
| MX (1) | MX361230B (pt) |
| RU (1) | RU2668795C2 (pt) |
| WO (1) | WO2012101112A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2689786A1 (en) | 2012-07-23 | 2014-01-29 | Genticel | HPV/CYAA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders |
| EP2690172A1 (en) * | 2012-07-23 | 2014-01-29 | Genticel | CYAA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses |
| WO2015077717A1 (en) | 2013-11-25 | 2015-05-28 | The Broad Institute Inc. | Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status |
| US11725237B2 (en) | 2013-12-05 | 2023-08-15 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
| WO2015095811A2 (en) | 2013-12-20 | 2015-06-25 | The Board Institute Inc. | Combination therapy with neoantigen vaccine |
| WO2016100975A1 (en) | 2014-12-19 | 2016-06-23 | Massachsetts Institute Ot Technology | Molecular biomarkers for cancer immunotherapy |
| EP3757211A1 (en) | 2014-12-19 | 2020-12-30 | The Broad Institute, Inc. | Methods for profiling the t-cell-receptor repertoire |
| EP3037103A1 (en) * | 2014-12-23 | 2016-06-29 | Genticel | Immunotherapeutic vaccine comprising E7 proteins of HPV16 and HPV18 fused with CyaA, for use in subjects infected with HPV |
| KR20180010229A (ko) | 2015-05-20 | 2018-01-30 | 더 브로드 인스티튜트, 인코퍼레이티드 | 공유 신생항원 |
| US10313363B2 (en) * | 2015-11-24 | 2019-06-04 | Bank Of America Corporation | Proactive intrusion protection system |
| EP3574116A1 (en) | 2017-01-24 | 2019-12-04 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
| US11793867B2 (en) | 2017-12-18 | 2023-10-24 | Biontech Us Inc. | Neoantigens and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0637335B1 (en) | 1992-04-21 | 2007-07-25 | Institut Pasteur | Recombinant mutants for inducing specific immune responses |
| ES2331348T3 (es) | 2000-09-15 | 2009-12-30 | Pasteur Institut | Vectores proteinicos para el suministro de moleculas a las celulas que expresan cd11b. |
| WO2005035557A2 (en) * | 2003-10-14 | 2005-04-21 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin | Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease |
| ATE450272T1 (de) * | 2003-11-21 | 2009-12-15 | Pasteur Institut | Rekombinantes adenylat-cyclase-toxin von bordetella induziert t-zell-antworten gegen tumorale antigene |
| SI1576967T1 (sl) * | 2004-03-18 | 2008-02-29 | Pasteur Institut | Rekombinantni protein, ki nosi epitope humanega papilomavirusa, vstavljene v adenilat ciklazni protein ali njegov fragment, in njegove terapevtske uporabe |
| TWI423814B (zh) * | 2006-09-01 | 2014-01-21 | Genticel | 用於引發特異性細胞毒性ｔ淋巴細胞（ｃｔｌ）反應之組成物，包含一淋巴去除性化合物以及一含有抗原序列且以專業化抗原呈現細胞為標靶之分子 |
| EP1894941A1 (en) * | 2006-09-01 | 2008-03-05 | Institut Pasteur | Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying HPV antigens |
| WO2008118592A2 (en) * | 2007-02-23 | 2008-10-02 | The Penn State Research Foundation | Use of an avirulent bordetella mutant as a live vaccine vector |
-
2011
- 2011-01-24 EP EP11305069A patent/EP2478915A1/en not_active Withdrawn
-
2012
- 2012-01-24 MX MX2013008606A patent/MX361230B/es active IP Right Grant
- 2012-01-24 WO PCT/EP2012/051027 patent/WO2012101112A1/en active Application Filing
- 2012-01-24 KR KR1020137022115A patent/KR101975610B1/ko active IP Right Grant
- 2012-01-24 AU AU2012210612A patent/AU2012210612B2/en not_active Ceased
- 2012-01-24 RU RU2013136148A patent/RU2668795C2/ru not_active IP Right Cessation
- 2012-01-24 JP JP2013549843A patent/JP6014604B2/ja not_active Expired - Fee Related
- 2012-01-24 CN CN2012800148671A patent/CN103476424A/zh active Pending
- 2012-01-24 EP EP12701110.4A patent/EP2667890B1/en active Active
- 2012-01-24 ES ES12701110T patent/ES2748381T3/es active Active
- 2012-01-24 BR BR112013018742A patent/BR112013018742A2/pt not_active Application Discontinuation
- 2012-01-24 US US13/981,250 patent/US9902947B2/en not_active Expired - Fee Related
- 2012-01-24 CA CA2825470A patent/CA2825470A1/en not_active Abandoned
-
2016
- 2016-06-01 JP JP2016110076A patent/JP2016208979A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016208979A (ja) | 2016-12-15 |
| JP2014506562A (ja) | 2014-03-17 |
| WO2012101112A1 (en) | 2012-08-02 |
| EP2667890A1 (en) | 2013-12-04 |
| RU2668795C2 (ru) | 2018-10-02 |
| MX2013008606A (es) | 2013-12-09 |
| US20140037670A1 (en) | 2014-02-06 |
| RU2013136148A (ru) | 2015-03-10 |
| MX361230B (es) | 2018-11-30 |
| AU2012210612B2 (en) | 2016-07-14 |
| KR101975610B1 (ko) | 2019-05-07 |
| KR20140034147A (ko) | 2014-03-19 |
| CA2825470A1 (en) | 2012-08-02 |
| AU2012210612A1 (en) | 2013-05-02 |
| US9902947B2 (en) | 2018-02-27 |
| EP2478915A1 (en) | 2012-07-25 |
| EP2667890B1 (en) | 2019-07-03 |
| CN103476424A (zh) | 2013-12-25 |
| JP6014604B2 (ja) | 2016-10-26 |
| ES2748381T3 (es) | 2020-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013018742A2 (pt) | cya-transportador de polipeptídeo(s) e use para induzir tanto as terapias e resposta imunitária profilática | |
| IL286784A (en) | Compositions of protein and antibody | |
| IL260045B (en) | Polypeptide structures and their uses | |
| HK1200871A1 (en) | Modified dna-binding proteins and uses thereof dna- | |
| BR112014018136A2 (pt) | anticorpos ou uso e método para determinar | |
| HK1212034A1 (en) | Antibodies to risperidone and use thereof | |
| CO7020851A2 (es) | Proteínas y péptidos modificados | |
| DK2793965T3 (da) | Vævsprodukter med flydeevne | |
| DK3195793T3 (da) | Forbedringer i eller relateret til oftalmologi | |
| HK1197187A1 (en) | Anti-lrp5 antibodies and methods of use lrp5 | |
| HK1211958A1 (en) | Antibodies to paliperidone and use thereof | |
| ZA201400562B (en) | Axmi205 variant proteins and methods for their use | |
| DK2705144T4 (da) | Polypeptid | |
| BR112014007961A2 (pt) | conjunto de propulsão para aeronave e aeronave | |
| HK1208053A1 (en) | Antibody against transporter and use thereof | |
| EP2734543A4 (en) | LACTOFERRIN FRAGMENTS AND USE THEREOF | |
| EP2785196A4 (en) | PROCESSES AND SYSTEMS FOR PROTEIN RECYCLING | |
| IL230474A0 (en) | Lactoferrin segments and their uses | |
| GB201320209D0 (en) | Improvements in or relating to protein Micro-nets | |
| BRDI7105248S (pt) | Configuração aplicada em andador | |
| GB201121233D0 (en) | Modified proteins and peptides | |
| GB201121226D0 (en) | Modified proteins and peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |